Merit Medical Systems will release its Q3 financial results on October 30, 2025, followed by an investor conference call.
Quiver AI Summary
Merit Medical Systems, Inc. announced that it will release its financial results for the third quarter of 2025 after the stock market closes on October 30, 2025. The company will also host an investor conference call at 5:00 p.m. Eastern time on the same day, for which interested participants need to pre-register to receive dial-in details. A live webcast and slide presentation will be available, with links accessible through the company's website. Founded in 1987, Merit Medical specializes in developing and distributing medical devices for various medical fields, including cardiology and oncology, and has a workforce of approximately 7,400 employees globally.
Potential Positives
- Merit Medical Systems is set to release its financial results, indicating transparency and commitment to keeping investors informed about company performance.
- The upcoming investor conference call is an opportunity for direct communication with shareholders, fostering engagement and trust.
- The company's established history since 1987 highlights its experience and reliability in the healthcare technology industry.
- Merit Medical's global presence and large workforce reflect its operational scale and capability to support a diverse customer base worldwide.
Potential Negatives
- None
FAQ
When will Merit Medical release its financial results?
Merit Medical will release its financial results for the quarter ended September 30, 2025, on October 30, 2025.
What time is the investor conference call scheduled?
The investor conference call is scheduled for 5:00 p.m. Eastern on October 30, 2025.
How can I access the conference call?
To access the conference call, please pre-register using the link provided in the announcement.
What is Merit Medical known for?
Merit Medical is a leading manufacturer of healthcare technology and medical devices used in various medical procedures.
How many employees does Merit Medical have worldwide?
Merit Medical employs approximately 7,400 people across the globe.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MMSI Congressional Stock Trading
Members of Congress have traded $MMSI stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MMSI stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 07/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MMSI Insider Trading Activity
$MMSI insiders have traded $MMSI stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $MMSI stock by insiders over the last 6 months:
- FRED P. LAMPROPOULOS (President and CEO) has made 0 purchases and 4 sales selling 40,400 shares for an estimated $3,872,144.
- F. ANN MILLNER sold 21,250 shares for an estimated $2,049,987
- RAUL JR. PARRA (CFO AND TREASURER) sold 15,181 shares for an estimated $1,423,218
- LYNNE N. WARD has made 0 purchases and 2 sales selling 5,433 shares for an estimated $472,215.
- DAVID FLOYD sold 3,515 shares for an estimated $330,972
- MICHAEL R. MCDONNELL has made 0 purchases and 2 sales selling 3,500 shares for an estimated $330,417.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MMSI Hedge Fund Activity
We have seen 178 institutional investors add shares of $MMSI stock to their portfolio, and 185 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 474,451 shares (-94.4%) from their portfolio in Q2 2025, for an estimated $44,351,679
- BLACKROCK, INC. removed 460,453 shares (-5.0%) from their portfolio in Q2 2025, for an estimated $43,043,146
- CITADEL ADVISORS LLC added 398,002 shares (+41.8%) to their portfolio in Q2 2025, for an estimated $37,205,226
- ARROWMARK COLORADO HOLDINGS LLC removed 341,220 shares (-34.4%) from their portfolio in Q2 2025, for an estimated $31,897,245
- UBS GROUP AG removed 332,413 shares (-44.2%) from their portfolio in Q2 2025, for an estimated $31,073,967
- NUVEEN, LLC removed 328,568 shares (-43.1%) from their portfolio in Q2 2025, for an estimated $30,714,536
- MILLENNIUM MANAGEMENT LLC added 259,743 shares (+563.7%) to their portfolio in Q2 2025, for an estimated $24,280,775
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MMSI Analyst Ratings
Wall Street analysts have issued reports on $MMSI in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 09/23/2025
- Wells Fargo issued a "Overweight" rating on 07/31/2025
- Raymond James issued a "Outperform" rating on 07/31/2025
- Piper Sandler issued a "Overweight" rating on 07/31/2025
- Needham issued a "Buy" rating on 07/18/2025
- Canaccord Genuity issued a "Buy" rating on 05/21/2025
- Baird issued a "Outperform" rating on 04/25/2025
To track analyst ratings and price targets for $MMSI, check out Quiver Quantitative's $MMSI forecast page.
$MMSI Price Targets
Multiple analysts have issued price targets for $MMSI recently. We have seen 7 analysts offer price targets for $MMSI in the last 6 months, with a median target of $105.0.
Here are some recent targets:
- Michael Petusky from Barrington Research set a target price of $103.0 on 09/23/2025
- Jason Bednar from Piper Sandler set a target price of $105.0 on 07/31/2025
- Larry Biegelsen from Wells Fargo set a target price of $100.0 on 07/31/2025
- Jayson Bedford from Raymond James set a target price of $102.0 on 07/31/2025
- Mike Matson from Needham set a target price of $108.0 on 07/18/2025
- Jon Young from Canaccord Genuity set a target price of $112.0 on 05/21/2025
- David Rescott from Baird set a target price of $110.0 on 04/25/2025
Full Release
SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).
To access the conference call, please pre-register using the following link . Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this link . A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.
| Contacts: | |
| PR/Media Inquiries: | Investor Inquiries: |
| Sarah Comstock | Mike Piccinino, CFA, IRC |
| Merit Medical | ICR Healthcare |
| +1-801-432-2864 | +1-443-213-0509 |
| [email protected] | [email protected] |
